Drugs are classified into two major categories based on their genetic makeup: chemical and biological. The WSJ’s Preetika Rana explains what their differences are and why drug companies are increasingly looking to biologics. Photo/video: Menglin Huang/The Wall Street JournalSUZHOU, China—A new cancer drug licensed by Eli Lilly & Co. was discovered by a six-year-old startup on the outskirts of Shanghai, and derived from the ovary cells of Chinese hamsters. Rival Merck & Co. aims to test a separate cancer drug in the U.S. this year, created by another startup near the border with Hong Kong. China, long the world’s...

Source: Wall Street Journal April 10, 2017 09:22 UTC